Diffuse parenchymal lung diseases - Histopathologic patterns

Progress in Respiratory Research

Volumn 36, Issue , 2007, Pages 44-57

  Chilosi, M ^a,d   Murer, B ^b   Poletti, V ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b Mestre Hospital   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

^d Anatomia Patologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49449100278     PISSN: 14222140     EISSN: 16623932     Source Type: Book Series    
DOI: 10.1159/000102625     Document Type: Review

References (49)

1. American Thoracic Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-664.
2. King TE Jr: Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med 2005;172:268-279.
3. Poletti V, Kitaichi M: Facts and controversies in the classification of idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:229-238.
4. Katzenstein AL, Myers JL: Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-1315.
5. Hunninghake GW, Zimmerman MB, Schwartz DA, King TE Jr, Lynch J, Hegele R, Waldron J, Colby T, Muller N, Lynch D, Galvin J, Gross B, Hogg J, Toews G, Helmers R, Cooper JA Jr, Baughman R, Strange C, Millard M: Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:193-196.
6. Selman M, King TE Jr, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151.
7. Nakamura Y, Chida K, Suda T, Hayakawa H, Iwata M, Imokawa S, Tsuchiya T, Ida M, Gemma H, Yasuda K, Yagi T, Shirai T, Tamura R, Nakano Y, Hirata T, Nakamura H, Colby TV: Nonspecific interstitial pneumonia in collagen vascular diseases: comparison of the clinical characteristics and prognostic significance with usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2003;20: 235-241.
8. Chilosi M, Poletti V, Zamo A, Lestani M, Montagna L, Piccoli P, Pedron S, Bertaso M, Scarpa A, Murer B, Cancellieri A, Maestro R, Semenzato G, Doglioni C: Aberrant Wnt/betacatenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003;162:1495-1502.
9. Chilosi M, Poletti V, Murer B, Semenzato G, Doglioni C: Bronchiolar epithelium in idiopathic pulmonary fibrosis/usual interstitial pneumonia; in Lynch JPI (ed): Idiopathic Pulmonary Fibrosis. Lung Biology in Health and Disease. New York, Marcel Dekker, 2004, pp 631-664.
10. King TE Jr, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA Jr, Flint A, Thurlbeck W, Cherniack RM: Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001;164:1025-1032.
11. Kaarteenaho-Wiik R, Tani T, Sormunen R, Soini Y, Virtanen I, Paakko P: Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am J Respir Crit Care Med 1996;154:511-518.
12. Chilosi M, Poletti V, Murer B, Lestani M, Cancellieri A, Montagna L, Piccoli P, Cangi G, Semenzato G, Doglioni C: Abnormal reepithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63. Lab Invest 2002;82:1335-1345.
13. Chilosi M, Zamò A, Doglioni C, Reghellin D, Lestani M, Montagna L, Pedron S, Ennas MG, Cancellieri A, Murer B, Poletti V: Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res 2006;7:95.
14. American Thoracic Society/European Respiratory Society: International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
15. Katzenstein AL, Fiorelli RF: Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-147.
16. Travis WD, Matsui K, Moss J, Ferrans VJ: Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000;24:19-33.
17. Yamadori I, Fujita J, Kajitani H, Bandoh S, Tokuda M, Yang Y, Ohtsuki Y, Yoshinouchi T, Kamei T, Ishida T: Lymphocyte subsets in lung tissues of non-specific interstitial pneumonia and pulmonary fibrosis associated with collagen vascular disorders: correlation with CD4/CD8 ratio in bronchoalveolar lavage. Lung 2000;178:361-370.
18. Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, Gross BH, Jain A, Strawderman RL, Flint A, Lynch JP, Martinez FJ: Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001;164:1722-1727.
19. Costabel U, Hunninghake GW: ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999;14:735-737.
20. Semenzato G, Pezzutto A, Pizzolo G, Chilosi M, Ossi E, Angi MR, Cipriani A: Immunohistological study in sarcoidosis: evaluation at different sites of disease activity. Clin Immunol Immunopathol 1984;30:29-40.
21. Gibbs AR, Williams WJ, Kelland D: Necrotising sarcoidal granulomatosis: a problem of identity: a study of seven cases. Sarcoidosis 1987;4: 94-100.
22. Agostini C, Facco M, Chilosi M, Semenzato G: Alveolar macrophage-T cell interactions during Th1-type sarcoid inflammation. Microsc Res Tech 2001;53:278-287.
23. Chilosi M, Mombello A, Montagna L, Benedetti A, Lestani M, Semenzato G, Menestrina F: Multimarker immunohistochemical staining of calgranulins, chloroacetate esterase, and S100 for simultaneous demonstration of inflammatory cells on paraffin sections. J Histochem Cytochem 1990;38:1669-1675.
24. Lacasse Y, Selman M, Costabel U, Dalphin JC, Ando M, Morell F, Erkinjuntti-Pekkanen R, Muller N, Colby TV, Schuyler M, Cormier Y, HP Study Group: Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003;168:952-958.
25. Coleman A, Colby TV: Histologic diagnosis of extrinsic allergic alveolitis. Am J Surg Pathol 1988;12:514-518.
26. Semenzato G, Agostini C, Zambello R, Trentin L, Chilosi M, Pizzolo G, Marcer G, Cipriani A: Lung T cells in hypersensitivity pneumonitis: phenotypic and functional analyses. J Immunol 1986;137:1164-1172.
27. Ohtani Y, Saiki S, Kitaichi M, Usui Y, Inase N, Costabel U, Yoshizawa Y: Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005;60:665-671.
28. Vourlekis JS, Schwarz MI, Cool CD, Tuder RM, King TE, Brown KK: Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med 2002;112:490-493.
29. Churg A, Myers J, Suarez T, Gaxiola M, Estrada A, Mejia M, Selman M: Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pathol 2004;28:62-68.
30. Nagai S, Hoshino Y, Hayashi M, Ito I: Smoking-related interstitial lung diseases. Curr Opin Pulm Med 2000;6:415-419.
31. Ryu JH, Colby TV, Hartman TE, Vassallo R: Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001;17:122-132.
32. Flaherty KR, Martinez FJ: Cigarette smoking in interstitial lung disease: concepts for the internist. Med Clin N Am 2004;88:1643-1653.
33. Selman M: The spectrum of smoking-related interstitial lung disorders: the never-ending story of smoke and disease. Chest 2003;124:1185-1187.
34. Fraig M, Shreesha U, Savici D, Katzenstein AL: Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002;26: 647-653.
35. Craig PJ, Wells AU, Doffman S, Rassl D, Colby TV, Hansell DM, Du Bois RM, Nicholson AG: Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004;45:275-282.
36. Moon J, du Bois RM, Colby TV, Hansell DM, Nicholson AG: Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999;54:1009-1014.
37. Marques LJ, Teschler H, Guzman J, Costabel U: Smoker's lung transplanted to a nonsmoker: long-term detection of smoker's macrophages. Am J Respir Crit Care Med 1997;156:1700-1702.
38. Buchino JJ, Keenan WJ, Algren JT, Bove KE: Familial desquamative interstitial pneumonitis occurring in infants. Am J Med Genet Suppl 1987;3:285-291.
39. Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM: Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001;25:630-636.
40. Sundar KM, Gosselin MV, Chung HL, Cahill BC: Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest 2003;123:1673-1683.
41. Soler P, Moreau A, Basset F, Hance AJ: Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. Am Rev Respir Dis 1989;139:1112-1117.
42. Vassallo R, Jensen EA, Colby TV, Ryu JH, Douglas WW, Hartman TE, Limper AH: The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003;124:1199-1205.
43. Pea M, Martignoni G, Zamboni G, Bonetti F: Perivascular epithelioid cell. Am J Surg Pathol 1996;20:1149-1153.
44. Bonetti F, Chiodera PL, Pea M, Martignoni G, Bosi F, Zamboni G, Mariuzzi GM: Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J Surg Pathol 1993;17:1092-1102.
45. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, Wallaert B, Petit H, Grimaldi A, Wechsler B, Godeau P: Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996;75:157-169.
46. Kenn W, Eck M, Allolio B, Jakob F, Illg A, Marx A, Mueller-Hermelink HK, Hahn D: Erdheim-Chester disease: evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with detailed radiological and immunohistochemical analysis. Hum Pathol 2000;31:734-739.
47. Rush WL, Andriko JA, Galateau-Salle F, Brambilla E, Brambilla C, Ziany-bey I, Rosado-de-Christenson ML, Travis WD: Pulmonary pathology of Erdheim-Chester disease. Mod Pathol 2000;13:747-754.
48. Maric I, Pittaluga S, Dale JK, Niemela JE, Delsol G, Diment J, Rosai J, Raffeld M, Puck JM, Straus SE, Jaffe ES: Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol 2005;29:903-911.
49. Bonetti F, Chilosi M, Menestrina F, Scarpa A, Pelicci PG, Amorosi E, Fiore-Donati L, Knowles DM: Immunohistological analysis of Rosai-Dorfman histiocytosis: a disease of S-100+ CD1- histiocytes. Virchows Arch [A] 1987;411:129-135.